Therapeutic Giving: Neuroscience: Local & Regional Organizations Grant

The Therapeutic Giving program from Johnson & Johnson Innovative Medicine aims to support local and regional organizations focused on improving patient access to treatment and advancing health equity. Eligible applicants include 501(c)(3) nonprofit organizations, with funding preferences for programs that address significant healthcare disparities, mental health initiatives, and innovative solutions with measurable outcomes. The application period for local organizations runs from March 1 to May 31, while national organizations can apply in September.

NOTE:
Application period for Local or Regional Organizations is March 1 – May 31.See page for National Organizations here. Application period is the month of September.For event-specific funding, applications must be submitted at least sixty (60) days prior to the event.
Janssen is interested in funding programs and initiatives that improve patient access to treatment and services, advance health equity and strengthen frontline health workforces within the therapeutic areas noted.
Disease Areas
Alzheimer’s DiseaseMajor Depressive DisorderSchizophreniaSchizoaffective Disorder
Areas of Interest
Recovery-focused programs, including initiatives on quality of life, coping, housing, social isolation, employment, and wellnessEarly intervention programsPrograms supporting access, continuity of care, and relapse preventionPrograms addressing healthcare disparities and the stigma associated with mental illnessCrisis intervention programsEducation and programs addressing mental health and the criminal justice systemInitiatives may be for patients, caregivers/families, peers, policy makers, community leaders, or the broader community

Eligibility

Only nonprofit organizations classified by the IRS as 501 (c)(3) are eligible to apply for a charitable contribution.All contribution requests are reviewed for compliance with our policies and relevant legal and industry requirements, including guidelines set forth by the Food and Drug Administration (FDA) and the Pharmaceutical Research and Manufacturers of America (PhRMA).Applications are evaluated competitively with emphasis given to innovative programs with measurable outcomes that address disparities or areas of high unmet need.Funding decisions will consider prevalence, population served, program design, organizational capacity, and anticipated outcomes.

Ineligibility

Faxed, e-mailed and postal-mailed requests will not be considered. Some requests or categories may not meet our guidelines for giving. These exclusions include the following:Organizations that do not have a valid non-profit, tax-exempt statusLoansTrips or toursSectarian and religious organizations that do not serve the general public on a nondenominational basisCapital requests (building funds, endowments, multi-year commitments) are generally not supportedPolitical groupsAdvocacy activities directed towards specific legislationOrganizations whose missions/objectives do not meet our contributions guidelinesDonations to individuals or to a charity on behalf of a customerEducational grants for healthcare professionals; see instead our education grants program for our funding priorities in this area.Research grantsCommercial Co-Ventures (CCV)